June 10, 2024

Parenteral Nutrition Market Size to Garner USD 11.62 Billion by 2032

The global parenteral nutrition market size was estimated to be around US$ 6.4 billion in 2022. It is projected to reach US$ 11.62 billion by 2032, indicating a CAGR of 6.2% from 2023 to 2032.

Parenteral Nutrition Market Size 2023 To 2032

Key Takeaways

  • North America dominated the market with the highest market share of 41% in 2022.
  • Asia-Pacific is expected to expand at the fastest CAGR during the forecast period.
  • By Nutrient Type, the single-dose amino acid solution segment has held the biggest revenue share of 31% in 2022.
  • By Nutrient Type, the trace elements segment is estimated to grow at a notable CAGR of 8.1% during the projected period.
  • By Stage Type, the adult segment captured more than 85% of revenue share in 2022.
  • By Stage Type, the single touch segment is projected to expand at the fastest CAGR over the projected period.
  • By Indication, the other segment contributes the largest revenue share of 31% in 2022.
  • By Indication, the alzheimer’s segment is estimated to grow at a remarkable 9.9% over the predicted period.
  • By Sales Channel, the institutional sales channel segment generated more than 49% in 2022.
  • By Sales Channel, the online sales segment is projected to expand at a remarkable CAGR of 11.8% over the predicted period.

Parenteral Nutrition Market  Overview:

The Parenteral Nutrition Market revolves around the provision of nutrients intravenously, bypassing the digestive system. This method is crucial for individuals who cannot consume food through the normal oral route, often due to severe illness, surgery, or other medical conditions. Parenteral nutrition typically involves the administration of a mixture of nutrients, including carbohydrates, proteins, lipids, vitamins, and minerals, directly into the bloodstream.

Get a Sample: https://www.precedenceresearch.com/sample/3417

Parenteral Nutrition Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 6.2%
Market Size in 2023 USD 6.76 Billion
Market Size by 2032 USD 11.62 Billion
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Nutrient Type, By Stage Type, By Indication, and By Sales Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Melanoma Therapeutics Market Size to Garner USD 14.59 Billion by 2032

Growth Factors:

Several factors contribute to the growth of the Parenteral Nutrition Market. The increasing prevalence of chronic diseases, such as cancer and gastrointestinal disorders, has led to a rising demand for parenteral nutrition as patients may face difficulties in nutrient absorption. Additionally, advancements in technology, formulation techniques, and the development of specialized nutrition solutions contribute to market growth. The aging population, coupled with a growing awareness of the importance of nutrition in healthcare, further propels the demand for parenteral nutrition products.

Regions:

The Parenteral Nutrition Market exhibits a global presence with significant growth observed across various regions. North America, with its advanced healthcare infrastructure and high healthcare spending, is a prominent market. Europe follows closely, driven by the increasing geriatric population and a robust healthcare system.

Parenteral Nutrition Market Share, By Region, 2022 (%)

Asia-Pacific is emerging as a lucrative market due to the rising prevalence of chronic diseases and improving healthcare facilities. Latin America and the Middle East also contribute to the market growth, albeit at a slightly slower pace, presenting opportunities for expansion in these regions.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Recent Developments

  • In November 2022, the Indian Society for Parenteral and Enteral Nutrition (ISPEN) officially endorsed the web-based application called iNutrimon. This application is designed to assist healthcare professionals in delivering optimal nutrition to patients who are in the process of recovery within healthcare facilities.
  • In February 2022, Pharmasyntez, a pharmaceutical company, made an announcement regarding its investment.

Parenteral Nutrition Market  Key Players

  • Baxter
  • Allergan
  • Actavis Inc.
  • Otsuka Pharmaceutical Factory, Inc.
  • Grifols, S.A.
  • B. Braun Melsungen AG
  • Vifor Pharma
  • Fresenius Kabi AG
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Pfizer Inc. (Hospira Inc.)

Market Segmentations

By Nutrient Type

  • Carbohydrates
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins & Minerals

By Stage Type

  • Adult
  • Pediatrics

By Indication

  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By Sales Channel

  • Online Sales
  • Retail Sales
  • Institutional Sales

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Parenteral Nutrition Market 

5.1. COVID-19 Landscape: Parenteral Nutrition Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Parenteral Nutrition Market, By Nutrient Type

8.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Nutrient Type, 2023-2032

8.1.1. Carbohydrates

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Parenteral Lipid Emulsion

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Single Dose Amino Acid Solution

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Trace Elements

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Vitamins & Minerals

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Parenteral Nutrition Market, By Stage Type

9.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Stage Type, 2023-2032

9.1.1. Adult

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Pediatrics

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Parenteral Nutrition Market, By Indication 

10.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Indication, 2023-2032

10.1.1. Alzheimer’s

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Nutrition Deficiency

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Cancer Care

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

10.1.4. Chronic Kidney Diseases

10.1.4.1. Market Revenue and Volume Forecast (2020-2032)

10.1.5. Orphan Diseases

10.1.5.1. Market Revenue and Volume Forecast (2020-2032)

10.1.6. Dysphagia

10.1.6.1. Market Revenue and Volume Forecast (2020-2032)

10.1.7. Pain Management

10.1.7.1. Market Revenue and Volume Forecast (2020-2032)

10.1.8. Malabsorption/GI Disorder/Diarrhea

10.1.8.1. Market Revenue and Volume Forecast (2020-2032)

10.1.9. Others

10.1.9.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Parenteral Nutrition Market, By Sales Channel 

11.1. Parenteral Nutrition Market Revenue and Volume Forecast, by Sales Channel, 2023-2032

11.1.1. Online Sales

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Retail Sales

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Institutional Sales

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Parenteral Nutrition Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Nutrient Type (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Stage Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Indication (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by Sales Channel (2020-2032)

Chapter 13. Company Profiles

13.1. Baxter

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Allergan

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Actavis Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Otsuka Pharmaceutical Factory, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Grifols, S.A.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. B. Braun Melsungen AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Vifor Pharma

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fresenius Kabi AG

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Sichuan Kelun Pharmaceutical Co., Ltd.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Pfizer Inc. (Hospira Inc.)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *